As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

Lisa Ricciardi, president and CEO of Cognition Therapeutics was recently a guest on Benzinga's All-Access. Cognition ...

Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.

The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS ...

Antibiotic use was not associated with an increased risk of cognitive impairment and dementia in healthy older adults, ...

All 16 of Indiana’s designated senior care organizations are now required to have a dementia outreach specialist. The goal is ...

Vitamin D also helps clear beta amyloid, a protein that plays a role in Alzheimer’s disease, Merrill points out. This is “the ...

Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.

A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...

The third most common form of dementia is often mistaken for Alzheimer's despite different treatment needsCognitive profiles ...

According to Phipps, the drugs currently available to treat Alzheimer’s have only eased the symptoms rather than stop its ...